Anúncio
Anúncio
VYNE
VYNE Therapeutics Inc. Common Stock
0.57
USDPatrocinado
0.00
-0.19%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
0.58
+0.01
+1.58%
Relatórios de Lucros VYNE
Rácio de surpresa positiva
VYNE separação 20 de 32 últimas estimativas.
63%
Próximo Relatório
Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$204.00K
/-$0.18
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+20.71%
/+5.88%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+142.86%
/-35.71%
VYNE Therapeutics Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, VYNE reported earnings of -0.17 USD per share (EPS) for Q3 25, missing the estimate of -0.13 USD, resulting in a -28.21% surprise. Revenue reached 169.00 mil, compared to an expected 102.00 mil, with a 65.69% difference. The market reacted with a +4.59% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -0.18 USD, with revenue projected to reach 204.00 mil USD, implying an aumentar of 5.88% EPS, and aumentar of 20.71% in Revenue from the last quarter.
FAQ
What were VYNE Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, VYNE Therapeutics Inc. Common Stock reported EPS of -$0.17, missing estimates by -28.21%, and revenue of $169.00K, 65.69% above expectations.
How did the market react to VYNE Therapeutics Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 4.59%, changed from $0.34 before the earnings release to $0.35 the day after.
When is VYNE Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for 04 de mar. de 2026.
What are the forecasts for VYNE Therapeutics Inc. Common Stock's next earnings report?
Based on 5
analistas, VYNE Therapeutics Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $204.00K for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio